'Invasive strategy' diaporamas de présentation

Antiplatelet Therapy in ACS and PCI: current state of the art and future therapies

1.23k views • 85 slides

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization)

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention (and Coronary Revascularization). GNL 2011. GNL 2011. Slide Set Organization. COR and LOE General Revascularization (CABG or PCI) Recommendations PCI Revascularization Recommendations Pre-Procedural Considerations

1.08k views • 69 slides

Acute Coronary Syndrome

Acute Coronary Syndrome. Steven R. Bruhl MD, MS 3 rd Year Cardiology Fellow Internal Medicine Didactics July 14, 2010. Goals and Objectives. Discuss the definition & pathophysiology of ACS Recognize the clinical features of low, intermediate and high risk ACS

995 views • 66 slides

Interventional Pharmacology: The Basics

Interventional Pharmacology: The Basics. Michael J. Cowley, FACC,FSCAI. Nothing to Disclose. Interventional Pharmacology. Heparin (UFH) GP IIb/IIIa Receptor Antagonists Low Molecular Weight Heparins Direct Thrombin Inhibitors Thienopyridines . Adjunctive Therapy for ACS / PCI.

999 views • 53 slides

Risk Stratification in ACS: Beyond Troponin Positivity

Risk Stratification in ACS: Beyond Troponin Positivity. Nick Curzen PhD FRCP FESC Wessex Cardiac Unit Southampton University Hospital. Acute Coronary Syndromes. Plaque erosion/fissuring/rupture. Platelet activation. Activation of white cells. Cytokines. Platelet aggregation.

808 views • 51 slides

Mx of UA and NSTEMI

Alyssa Morris, R4 September 30, 2010. Mx of UA and NSTEMI. OBJECTIVES. Mx of UA/NSTEMI in the ED CRUSADE, COMMIT, ISIS-2, CAPRIE, CURE, PCI-CURE, OASIS-5, OASIS- 7, SYNERGY NOT covering GPIIb/IIIa inhibitors Statins Decision to go to PCI or medical management Variants of ACS.

713 views • 48 slides

Umberto Baldini Cardiologia - Livorno

747 views • 44 slides

Giuseppe Biondi Zoccai University of Turin , Turin , Italy METCARDIO, Turin , Italy gbiondizoccai@gmail.com

636 views • 42 slides

Gregg W. Stone MD for the ACUITY Investigators

ACUITY PCI A Prospective Trial of Patients with ACS Undergoing PCI after Randomization to Heparin plus GP IIb/IIIa Inhibitors vs. Bivalirudin With or Without GP IIb/IIIa Inhibitors. Gregg W. Stone MD for the ACUITY Investigators. Disclosure. Gregg W. Stone

549 views • 40 slides

STEMI VS Non STEMI COMPARISON IN ADMITTED MANAGEMENT

1.26k views • 40 slides

Angiographic Findings in Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial

Angiographic Findings in Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) Trial. Alexandra J. Lansky 1 , Ken Mori 1 , Ricardo A. Costa 1 , Michel Bertrand 2 , Frederick Feit 3 , Cordy Pietras 1 , Ecatarina Cristea 1 , Stuart Pocock 4 , Magnus Ohman 5 , Gregg W. Stone 1.

663 views • 24 slides

TAO : Treatment of Acute Coronary Syndromes with Otamixaban

408 views • 24 slides

TIMACS

TIMACS. Tim. ing of Intervention. in patients with. A. cute. C. oronary. S. yndromes. An International Randomized Trial of Early Versus Delayed Invasive Strategies in Patients with Non-ST Segment Elevation Acute Coronary Syndromes. Preliminary Results.

551 views • 24 slides

La preparazione alla PTCA nelle sindromi coronariche acute Area Emergenza Urgenza ANMCO

La preparazione alla PTCA nelle sindromi coronariche acute Area Emergenza Urgenza ANMCO Roma 20 marzo 2010 La preparazione farmacologica alla PTCA : trattamento antiaggregante/anticoagulante precoce o in sala di emodinamica? Cesare Greco Cardiologia III Ospedale S Giovanni- Roma.

440 views • 23 slides

TACTICS-TIMI 18 Economics & HRQOL

TACTICS-TIMI 18 Economics & HRQOL. T reat Angina with A ggrastat and Determine C ost of T herapy with an I nvasive or C onservative S trategy . Economic & QoL Substudy. Economic Data Coordination William Weintraub, MD, Steven Culler, PhD

398 views • 22 slides

OASIS-5

OASIS-5. The Fifth O rganization to A ssess S trategies in Acute I schemic S yndromes trial . US hospital discharges in ACS. Acute coronary syndromes. 1.67 million hospital discharges/year. UA/NSTEMI. STEMI. 1.17 million. 500,000.

704 views • 18 slides

Background

A Pharmaco-invasive Reperfusion Strategy with Immediate Percutaneous Coronary Intervention is Safe and Effective in ST-Elevation Myocardial Infarction Patients with Expected Delays Due to Long Distance Transfer.

389 views • 18 slides

STREAM - One YEAR Mortality Strategic Reperfusion Early After Myocardial Infarction

STREAM - One YEAR Mortality Strategic Reperfusion Early After Myocardial Infarction. STREAM design. STEMI <3 hrs from onset symptoms, PPCI <60 min not possible, 2 mm ST-elevation in 2 leads . RANDOMIZATION 1:1 by IVRS, OPEN LABEL. Strategy B: primary PCI. Strategy A: pharmaco-invasive.

287 views • 15 slides

Presented at The European Society of Cardiology Scientific Congress 2006

FRISC II Trial. Fragmin and Fast Revascularization during Instability in Coronary Artery Disease (FRISC II): Five-Year Follow-up of the FRISC-II Invasive Study. Presented at The European Society of Cardiology Scientific Congress 2006 Presented by Dr. Bo Lagerqvist.

304 views • 8 slides

Invasive versus non-invasive strategy in NON-STEMI: SWEDEHEART

Invasive versus non-invasive strategy in NON-STEMI: SWEDEHEART.

139 views • 4 slides